Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

> 据报道，Colossal Biosciences 正在洽谈以200亿至300亿美元估值进行新一轮融资。

作者: Marina Temkin | 来源: TechCrunch | 时间: Mon, 20 Jul 2026 23:39:35 +0000

When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy surrounding the project, the company was building valuable technologies that justify its $10.2 billion valuation.

⋯ 继续阅读请开通会员 ⋯